
Problem statement
Regulatory and clinical QC reviewers manually cross-check trial documentation against ever-changing regulatory requirements, a slow process prone to missed findings. Build an AI-powered regulatory QC solution that reviews clinical documentation against current requirements and flags gaps or inconsistencies before submission, reducing review cycle time and audit risk.
One-pager
ClinQC Studio
AI Clinical Quality Intelligence Prototype
Prototype Overview |
Prototype Name: ClinQC Studio |
ClinQC Studio is an AI-powered clinical quality intelligence prototype designed to unify quality oversight across Trial Master File documentation, clinical trial data review, protocol deviation monitoring, and inspection readiness. It brings together fragmented quality signals into a single command-center experience, so clinical teams can identify risks earlier, act faster, and improve regulatory preparedness across the trial.
What the Prototype Is About |
The prototype was conceptualized to address a growing challenge in clinical operations: regulatory expectations for continuous, risk-based quality oversight are increasing, while most quality teams still work across disconnected systems and manual review processes. ClinQC Studio is positioned as a practical response to this shift, using AI-enabled workflows to support earlier detection of document gaps, data anomalies, protocol deviations, and emerging inspection risks.
Key Problem It Addresses |
Clinical quality management is often reactive. Quality teams typically manage eTMF review, EDC data checks, and deviation tracking in separate workflows, which creates limited visibility across the full study quality picture. As a result, critical issues such as incomplete TMF documentation, unresolved data inconsistencies, repeated deviations, or readiness gaps may only become visible during late-stage review or pre-inspection preparation.
ClinQC Studio addresses this gap by enabling a more connected and proactive quality oversight model. The goal is to help sponsors, CROs, and clinical quality teams move from manual, siloed review practices toward a more continuous and risk-informed approach aligned with current GCP expectations.
Key Features |
1. eTMF Document Intelligence • Supports AI-assisted classification of Trial Master File documents. • Flags potentially missing, incomplete, or misfiled artifacts for reviewer attention. • Improves visibility into document quality and completeness across the study record. | 2. EDC Data Anomaly Detection • Surfaces with unusual or inconsistent data patterns within clinical trial datasets. • Enables an earlier review of potential data quality issues that may affect trial reliability. • Supports more consistent query generation and review workflows. |
3. Protocol Deviation Monitoring • Tracks deviations in a structured manner across sites and studies. • Helps identify repeat patterns and areas requiring deeper quality review. • Supports more informed corrective and preventive action planning. | 4. Inspection Readiness Scoring • Provides a forward-looking view of study readiness from a quality and compliance standpoint. • Highlights areas that may require remediation before regulatory review or inspection of activity. • Encourage continuous readiness rather than last-minute preparation. |
5. Unified Quality Dashboard • Brings documents, data, deviation, and readiness signals into one integrated interface. • Supports clearer oversight for quality, operations, and regulatory stakeholders. • Improves decision-making through a consolidated quality view. | |
Expected Business Impact |
ClinQC Studio is expected to strengthen clinical quality operations in several ways. By improving visibility across key quality domains, it can help reduce manual effort, shorten review cycles, and support earlier intervention on emerging risks. Its unified approach also supports stronger inspection preparedness and better operational alignment with modern risk-based quality management expectations under ICH E6(R3).
Expected impact areas include:
Faster quality review and issue of triage. | Improved cross-functional visibility across quality signals. |
Better preparedness for inspection and audit activity. | More proactive identification of compliance and operational risk. |
Stronger foundation for scalable AI adoption in clinical quality workflows. | |
Intended Audience |
This prototype is relevant for clinical quality assurance teams, CRO quality leads, sponsors, clinical data managers, and regulatory stakeholders seeking a more connected approach to trial quality oversight. |
FDX Context |
ClinQC Studio reflects Agilisium's FDX model, in which domain and AI expertise are embedded within life sciences workflows to design and operationalize solutions that address real business process |